Literature DB >> 8605204

A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.

S Modi1, M J Paine, M J Sutcliffe, L Y Lian, W U Primrose, C R Wolf, G C Roberts.   

Abstract

The cytochrome P450 responsible for the debrisoquine/sparteine polymorphism (P450 2D6) has been produced in large quantities by expression of a modified cDNA in baculovirus. A polyhistidine extension was incorporated at the C-terminus of the expressed protein, which, after purification of the protein on a nickel-agarose column, could be removed proteolytically by treatment with thrombin. Purified yields of P450 2D6 were 2.4 mg from 700 mL of cell culture. The protein had a greater than 90% heme content and was fully active, having no residual absorbance at 420 nm in the reduced CO complex. The quantities produced allowed direct study of the interaction of the substrate codeine with the enzyme by paramagnetic relaxation effects on the NMR spectrum of the substrate. Distances between the heme iron atom and substrate protons were calculated from these experiments, and the orientation of the substrate in the binding pocket was determined. This showed that codeine was bound with the methoxy group of the molecule closest to the heme iron (iron-methyl proton distance of 3.1 +/- 0.1 A), consistent with the observed O-demethylation to morphine. A model of the complex Of P450 2D6 with codeine was built from a multiple sequence and structure alignment of the known crystal structures for P450s, incorporating the experimental constraints derived from the NMR studies. This showed that the overall fold Of P450 2D6 is more similar to that of P450 BM3 than to either P450 cam or P450 terp. Codeine binds to P450 2D6 so that the methoxy group is directly above the A ring of the heme, while the basic nitrogen interacts with the carboxylate of aspartate 301.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605204     DOI: 10.1021/bi952742o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4.

Authors:  F De Rienzo; F Fanelli; M C Menziani; P G De Benedetti
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.

Authors:  Q Zhao; S Modi; G Smith; M Paine; P D McDonagh; C R Wolf; D Tew; L Y Lian; G C Roberts; H P Driessen
Journal:  Protein Sci       Date:  1999-02       Impact factor: 6.725

Review 3.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

4.  Isolation and characterization of the CYP2D6 gene in Felidae with comparison to other mammals.

Authors:  Tamara Schenekar; Kathrin A Winkler; Jennifer L Troyer; Steven Weiss
Journal:  J Mol Evol       Date:  2010-12-28       Impact factor: 2.395

5.  CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant.

Authors:  Matthew A Hummel; Charles W Locuson; Peter M Gannett; Dan A Rock; Carrie M Mosher; Allan E Rettie; Timothy S Tracy
Journal:  Mol Pharmacol       Date:  2005-06-13       Impact factor: 4.436

Review 6.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

7.  Substrate proton to heme distances in CYP2C9 allelic variants and alterations by the heterotropic activator, dapsone.

Authors:  Matthew A Hummel; Peter M Gannett; Jarrett Aguilar; Timothy S Tracy
Journal:  Arch Biochem Biophys       Date:  2008-05-01       Impact factor: 4.013

8.  Comparative protein structure modeling using Modeller.

Authors:  Ben Webb; Andrej Sali; Narayanan Eswar; Marc A Marti-Renom; M S Madhusudhan; David Eramian; Min-Yi Shen; Ursula Pieper
Journal:  Curr Protoc Bioinformatics       Date:  2006-10

9.  Ab initio molecular modeling in the study of drug metabolism.

Authors:  M D Segall; M C Payne; S W Ellis; G T Tucker; R N Boyes
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

Review 10.  The other kind of biological NMR--studies of enzyme-substrate interactions.

Authors:  G C Roberts
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.